2-[(3R,4R)-1-ethoxycarbonyl-4-[3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]pyrrolidin-3-yl]acetic acid

C27H30N2O6 — CID 10073789

IUPAC2-[(3R,4R)-1-ethoxycarbonyl-4-[3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]pyrrolidin-3-yl]acetic acid
SMILESCCOC(=O)N1C[C@H](CC(=O)O)[C@H](c2cccc(OCCc3nc(-c4ccccc4)oc3C)c2)C1
InChIInChI=1S/C27H30N2O6/c1-3-33-27(32)29-16-21(15-25(30)31)23(17-29)20-10-7-11-22(14-20)34-13-12-24-18(2)35-26(28-24)19-8-5-4-6-9-19/h4-11,14,21,23H,3,12-13,15-17H2,1-2H3,(H,30,31)/t21-,23-/m0/s1
InChIKeyILEXZBDONRTJAW-GMAHTHKFSA-N
MW478.55 g/mol
LogP4.92
Rot. Bonds9

About 2-[(3R,4R)-1-ethoxycarbonyl-4-[3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]pyrrolidin-3-yl]acetic acid

2-[(3R,4R)-1-ethoxycarbonyl-4-[3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]pyrrolidin-3-yl]acetic acid (PubChem CID 10073789) has the molecular formula C27H30N2O6 and a molecular weight of 478.55 g/mol. Its IUPAC name is 2-[(3R,4R)-1-ethoxycarbonyl-4-[3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]pyrrolidin-3-yl]acetic acid.

Molecular Properties

Compound Name2-[(3R,4R)-1-ethoxycarbonyl-4-[3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]pyrrolidin-3-yl]acetic acid
PubChem CID10073789
Molecular FormulaC27H30N2O6
Molecular Weight478.55 g/mol
Exact Mass478.21
IUPAC Name2-[(3R,4R)-1-ethoxycarbonyl-4-[3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]pyrrolidin-3-yl]acetic acid
SMILESCCOC(=O)N1C[C@H](CC(=O)O)[C@H](c2cccc(OCCc3nc(-c4ccccc4)oc3C)c2)C1
InChIInChI=1S/C27H30N2O6/c1-3-33-27(32)29-16-21(15-25(30)31)23(17-29)20-10-7-11-22(14-20)34-13-12-24-18(2)35-26(28-24)19-8-5-4-6-9-19/h4-11,14,21,23H,3,12-13,15-17H2,1-2H3,(H,30,31)/t21-,23-/m0/s1
InChIKeyILEXZBDONRTJAW-GMAHTHKFSA-N
XLogP4.92
TPSA102.10 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds9
Heavy Atoms35
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500478.55
LogP ≤ 54.92
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Analyze 2-[(3R,4R)-1-ethoxycarbonyl-4-[3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]pyrrolidin-3-yl]acetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[(3R,4R)-1-ethoxycarbonyl-4-[3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]pyrrolidin-3-yl]acetic acid?
The IUPAC name of 2-[(3R,4R)-1-ethoxycarbonyl-4-[3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]pyrrolidin-3-yl]acetic acid (CID 10073789) is 2-[(3R,4R)-1-ethoxycarbonyl-4-[3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]pyrrolidin-3-yl]acetic acid.
What is the SMILES notation for 2-[(3R,4R)-1-ethoxycarbonyl-4-[3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]pyrrolidin-3-yl]acetic acid?
The canonical SMILES for 2-[(3R,4R)-1-ethoxycarbonyl-4-[3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]pyrrolidin-3-yl]acetic acid is CCOC(=O)N1C[C@H](CC(=O)O)[C@H](c2cccc(OCCc3nc(-c4ccccc4)oc3C)c2)C1.
What is the InChIKey of 2-[(3R,4R)-1-ethoxycarbonyl-4-[3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]pyrrolidin-3-yl]acetic acid?
The InChIKey is ILEXZBDONRTJAW-GMAHTHKFSA-N. The full InChI is InChI=1S/C27H30N2O6/c1-3-33-27(32)29-16-21(15-25(30)31)23(17-29)20-10-7-11-22(14-20)34-13-12-24-18(2)35-26(28-24)19-8-5-4-6-9-19/h4-11,14,21,23H,3,12-13,15-17H2,1-2H3,(H,30,31)/t21-,23-/m0/s1.
What are the key properties of 2-[(3R,4R)-1-ethoxycarbonyl-4-[3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]pyrrolidin-3-yl]acetic acid?
2-[(3R,4R)-1-ethoxycarbonyl-4-[3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]pyrrolidin-3-yl]acetic acid has a molecular weight of 478.55 g/mol, XLogP of 4.92, 9 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(3R,4R)-1-ethoxycarbonyl-4-[3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]pyrrolidin-3-yl]acetic acid is sourced from PubChem (CID 10073789), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).